Medicare DES Rates Sustained; CMS Cites Paltry Data To Back DRG Change
This article was originally published in The Gray Sheet
Executive Summary
CMS will reconsider proposals to restructure the drug-eluting stent DRGs in 11 months after more data become available to support industry and physician assertions of significant cost differences between complex and non-complex cases
You may also be interested in...
CMS Creates New Stent DRGs, But Multi-Stent DRG Likely Two Years Away
Drug-eluting stent manufacturers face an uphill battle in convincing CMS to create inpatient Medicare DRGs for multiple-coronary-stent procedures before 2008
CMS Creates New Stent DRGs, But Multi-Stent DRG Likely Two Years Away
Drug-eluting stent manufacturers face an uphill battle in convincing CMS to create inpatient Medicare DRGs for multiple-coronary-stent procedures before 2008
DRG Split For Complex DES May Herald Multi-Vessel Payment Reforms
CMS remains open to considering whether inpatient diagnosis-related groups (DRGs) for drug-eluting stents should reflect differences in the number of stents implanted and/or vessels treated